Participant characteristics of the validation study by case definition (n = 218)
| Characteristics . | Control (n = 100) . | Slow-growing AAA (n = 89) . | Fast-growing AAA (n = 29) . |
|---|---|---|---|
| Age, y | 71.2 (8.4) | 71.8 (8.4) | 71.7 (8.1) |
| Sex | |||
| Male | 68 (68.0) | 72 (80.9) | 23 (79.3) |
| Female | 32 (32.0) | 17 (19.1) | 6 (20.7) |
| Race | |||
| White | 86 (86.0) | 84 (94.4) | 25 (86.2) |
| Other | 14 (14.0) | 5 (5.6) | 4 (13.8) |
| Height, in | — | 70 (67, 71) | 68 (65, 72) |
| Weight, kg | — | 83.5 (70.9, 95.7) | 82.6 (69.5, 102.5) |
| CAD | — | 42 (47.2) | 17 (58.6) |
| Hypertension | — | 76 (85.4) | 26 (89.7) |
| HLD | — | 76 (85.4) | 26 (89.7) |
| CKD | — | 19 (21.4) | 16 (55.2) |
| COPD | — | 32 (36.0) | 14 (48.3) |
| Diabetes | — | 25 (28.1) | 11 (37.9) |
| Aspirin use | — | 60 (67.4) | 20 (69.0) |
| Statin use | — | 65 (73.0) | 23 (79.3) |
| Current smoker | — | 26 (29.2) | 12 (41.4) |
| Growth, mm/y | — | 1 (0, 2) | 6 (5, 8) |
| Characteristics . | Control (n = 100) . | Slow-growing AAA (n = 89) . | Fast-growing AAA (n = 29) . |
|---|---|---|---|
| Age, y | 71.2 (8.4) | 71.8 (8.4) | 71.7 (8.1) |
| Sex | |||
| Male | 68 (68.0) | 72 (80.9) | 23 (79.3) |
| Female | 32 (32.0) | 17 (19.1) | 6 (20.7) |
| Race | |||
| White | 86 (86.0) | 84 (94.4) | 25 (86.2) |
| Other | 14 (14.0) | 5 (5.6) | 4 (13.8) |
| Height, in | — | 70 (67, 71) | 68 (65, 72) |
| Weight, kg | — | 83.5 (70.9, 95.7) | 82.6 (69.5, 102.5) |
| CAD | — | 42 (47.2) | 17 (58.6) |
| Hypertension | — | 76 (85.4) | 26 (89.7) |
| HLD | — | 76 (85.4) | 26 (89.7) |
| CKD | — | 19 (21.4) | 16 (55.2) |
| COPD | — | 32 (36.0) | 14 (48.3) |
| Diabetes | — | 25 (28.1) | 11 (37.9) |
| Aspirin use | — | 60 (67.4) | 20 (69.0) |
| Statin use | — | 65 (73.0) | 23 (79.3) |
| Current smoker | — | 26 (29.2) | 12 (41.4) |
| Growth, mm/y | — | 1 (0, 2) | 6 (5, 8) |
Values are presented as mean (SD) or n (%).
CAD, coronary artery disease; CKD, chronic kidney disease; COPD, chronic obstructive pulmonary disease; HLD, hyperlipidemia.